The mitochondrial transporter of ascorbic acid functions with high affinity in the presence of low millimolar concentrations of sodium and in the absence of calcium and magnesium  by Fiorani, Mara et al.
Biochimica et Biophysica Acta 1848 (2015) 1393–1401
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe mitochondrial transporter of ascorbic acid functions with high
afﬁnity in the presence of lowmillimolar concentrations of sodiumand in
the absence of calcium and magnesiumMara Fiorani a, Catia Azzolini a, Liana Cerioni a, Maddalena Scotti a, Andrea Guidarelli a,
Caterina Ciacci b, Orazio Cantoni a,⁎
a Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, 61029 Urbino, Italy
b Dipartimento di Scienze della Terra, della Vita e dell'Ambiente, Università degli Studi di Urbino “Carlo Bo”, 61029 Urbino, ItalyAbbreviations:AA, L-ascorbic acid; DHA, dehydroascor
IB, intracellular buffer;MB,mitochondrial buffer; SVCT, sod
⁎ Corresponding author. Tel.: +39 0722 303523; fax: +
E-mail address: orazio.cantoni@uniurb.it (O. Cantoni).
http://dx.doi.org/10.1016/j.bbamem.2015.03.009
0005-2736/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 10 November 2014
Received in revised form 13 February 2015
Accepted 10 March 2015
Available online 15 March 2015
Keywords:
Ascorbic acid transport
Mitochondria
Ascorbic acid
Na+-dependent ascorbic acid transporter 2We recently reported that U937 cell mitochondria express a functional Na+-dependent ascorbic acid (AA) trans-
porter recognised by anti-SVCT2 antibodies. The present study conﬁrms and extends these observations by
showing that this transporter is characterised by a Km and a pH-dependence comparable with that reported
for the plasma membrane SVCT2. In isolated mitochondria, Na+ increased AA transport rate in a cooperative
manner, revealed by a sigmoid curve and a Hill coefﬁcient of 2, as also observed in intact Raw 264.7 cells (uniquely
expressing SVCT2). There was however a striking difference on the Na+ concentrations necessary to reach satura-
tion, i.e., 1 or 100 mM for the mitochondrial and plasma membrane transporters, respectively. Furthermore the
mitochondrial, unlike the plasma membrane, transporter was fully active also in the absence of added Ca++
and/or Mg++.
Taken together, the results presented in this study indicate that the U937 cell mitochondrial transporter of AA,
because of its very low requirement for Na+ and independence for Ca++ and Mg++, displays kinetic character-
istics surprisingly similar with those of the plasma membrane SVCT2.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Vitamin C is a very important water soluble vitamin taken up
directly by the cells as L-ascorbic acid (AA) via high afﬁnity/low capacity
Na+-dependent transporters 1 and 2 (SVCT1 and 2) [1–3]. In alterna-
tive, cells may also take up the vitamin as dehydroascorbic acid (DHA)
through hexose transporters [4,5], an event followed by the rapid intra-
cellular reduction back to AA [6–8]. While this second mechanismmight
appear advantageous because of its high capacity, its involvement is
clearly conditioned by the extracellular levels of DHA, normally in the
very low micromolar range with some variation associated with the
release of AA oxidizing species, as the superoxide anion [9].
Regardless of the mechanism of uptake, however, cells may accumu-
late large amounts of vitamin C in the cytosol and, at least in principle,
in other subcellular compartments provided of adequate transport
systems of the vitamin. One of such compartments is represented by
the mitochondria, as these organelles actively produce reactive oxygen
species and are therefore expected to beneﬁt of the antioxidant activitybic acid; EB, extracellular buffer;
ium-AA co-transporter
39 0722 303521.of AA [10], based on direct scavenging of reactive species [11] and on
other activities related to vitamin E recycling [12]. Not surprisingly,
mitochondrial vitamin C has been detected in in vivo studies and was
found to increase upon dietary supplementation of the vitamin [13–15].
Themechanismwhereby the vitamin is taken up by themitochondria
has been attributed for a long time to DHA transport for at least two
separate reasons: i) hexose transporters are expressed in mitochondria
[15–18], despite the lack of an apparent role of glucose in mitochondrial
metabolism; ii) a high capacity transport is expected to be advantageous
under conditions of extensivemitochondrial formation of reactive oxygen
species.
Along the same lines, the possibility of a mitochondrial AA transport
has been considered unlikely because of the high afﬁnity of SVCTs,
allowing the full expression of their activity at AA concentrations re-
markably lower than those detected in the cytosol of many cell types
in vivo [19,20]. While this consideration deserves further discussion,
there are two additional reasons arguing against a role of SVCTs inmito-
chondrial AA transport. The ﬁrst one is based on the well established
Na+-dependence of these transporters [1], the activity of which does
not appear compatible with the concentrations of the cation in the in-
tracellular ﬂuids. The second reason against the mitochondrial location
(and function) of SVCT2 is based on its Ca++-requirements for the
expression of maximal activity [21]. Under resting conditions, there is
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between the extra and intracellular compartments, with a possibility of
a transient increase upon stimulation [22], however leading to Ca++ con-
centrations still remarkably lower than those found in the extracellular
milieu.
The above considerations have therefore stimulated various investi-
gations providing experimental evidence of efﬁcient mitochondrial
transport of DHA, however often using high DHA concentrations
[15–18]. The available evidence is in any case in keeping with the possi-
bility of a physio-pathological relevance of mitochondrial DHA uptake in
some conditions. This mechanism has the advantage of linking DHA for-
mation (and hence the formation of AA oxidizing species) with rapid
DHA transport and reduction back to AA. In other words, AA might be
rapidly accumulated in mitochondria under the same conditions in
which these organelles produce the superoxide anion.
Despite these observations and logical considerations, however, we
recently provided evidence for the presence of SVTC2 immunoreactivity
in U937 cell mitochondria [23]. Exposure of these cells to AA was asso-
ciated with themitochondrial accumulation of even low concentrations
of the vitamin. Our results were recently conﬁrmed by another group in
a different cell type [24]. These Authors, while providing solid and deﬁn-
itive evidence for the mitochondrial expression of a functional SVCT2,
also demonstrated that because of the intracellular environment low
in Na+ and high in K+, the mitochondrial SVCT2 functions with low
afﬁnity.
The present study, conﬁrms and extends our previousﬁndings [23] by
showing that the U937 cell mitochondrial AA transporter is surprisingly
characterised by a Km similar to that of the plasma membrane SVCT2.
An additional similarity was found in the pH-dependence and positive
cooperativity for Na+ (nH ≅ 2). Strikingly, however, 100 fold less Na+
was necessary to maximally support AA transport in mitochondria in
comparison with the transport through the plasma membrane. A ﬁnal
critical difference was found for the Ca++/Mg++ dependence, as plasma
membrane SVCT2 required very high (millimolar) concentrations
(normally present in extracellular ﬂuids), in contrast with themitochon-
drial transporter, fully active also in the absence of added Ca++. Our re-
sults are therefore consistent with the possibility that mitochondrial
SVCT2 might function with different afﬁnities, including the very high
afﬁnity that the same transporter displays in the plasma membrane. In
order to acquire this phenotype, the mitochondrial SVCT2 reduces its
cation requirements for optimal activity.
2. Materials and methods
2.1. Chemicals
AA, dithiothreitol (DTT), choline-chloride, 4-
Morpholineethanesulfonic acid hemisodium salt (MES) and most of
the reagent-grade chemicals were purchased from Sigma-Aldrich
(Milan, Italy). Perkin–Elmer Life and Analytical Sciences (Boston,
MA, USA) supplied the L-[1-14C]-ascorbic acid (speciﬁc activity
5.35 mCi/mmol), which was dissolved in deionized water containing
0.1 mM acetic acid and stored in multiple aliquots at−20 °C until use
[25]. The antibodies against SVCT2 (sc-9926), cytochrome c (sc-7159)
calnexin (sc-6465), HSP-60 (sc-13115), as well as the horseradish
peroxidase-conjugated secondary antibodies (sc-2350; sc-2005) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA); antibodies
against GLUT3 (ab53095) and lamin A (ANT0072) were from Abcam
(Cambridge, UK) and Diatheva (Fano, Italy), respectively.
2.2. Cell culture and treatment conditions
U937 human myeloid leukaemia cells and Raw 264.7 murine macro-
phages were cultured in RPMI 1640 medium (Sigma-Aldrich) supple-
mented with 10% heat-inactivated FBS (Euroclone, Celbio Biotecnologie,
Milan, Italy), penicillin (100 units/ml) and streptomycin (100 μg/ml)(Euroclone). The cells were grown at 37 °C in T-75 tissue culture ﬂasks
(Corning, Corning, NY) gassed with an atmosphere of 95% air—5% CO2.
Cells (1 × 106 cells/ml) were exposed for 5 min to AA or 14C-AA (speciﬁc
activity 5.35 mCi/mmol) in extracellular buffer, EB (15 mM Hepes,
135 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, pH 7.4) in the
presence of 0.1 mM DTT.
A 10mMAA stock solutionwas prepared in immediately before use.
Stability of AA (30 μM) in the above EB was assessed by monitoring
the absorbance at 267 nm for 90 min (ε267 = 14,600 M−1 cm−1). In
selected experiments, NaCl was replaced with choline-chloride.
2.3. Measurement of ascorbic acid content by HPLC
After treatments, the cells or mitochondria were washed twice with
cold EB or IB respectively and the ﬁnal pellets were extracted with ice-
cold 70% (v/v) methanol/30% solution (10 mM tetrabutylammonium
hydrogen sulphate, 10 mM KH2PO4, 0.5% methanol, pH 6.0) containing
1 mM EDTA and 10 mM DTT. After 10 min at ice bath temperature,
the samples were centrifuged at 10,000 g for 20 min at 4 °C. Samples
were ﬁltered through a 0.22 μm ﬁlter (Millipore Corporation, Billerica,
MA, USA) and either analysed immediately or frozen at −80 °C for
later analysis. AA content wasmeasured by HPLCwith the UV detection
wavelength set at 265 nm, as described in [26], with minor modiﬁca-
tions. The assay involved the use of a 15 cm × 4.6 mm Discovery C-18,
5 μmcolumn (Supelco, Bellefonte, PA, USA) equippedwith a Supelguard
Discovery C-18 guard column (2 cm × 4 mm, 5 μm). The injection
volume was 20 μl. Under these conditions the retention time of AA
was about 4 min. AA concentration was determined from the corre-
sponding calibration curve constructed with the pure chemical AA
dissolved in the extraction solution.
2.4. Measurement of 14C-AA cellular uptake
Uptakewas stopped bywashing the cells two timeswith ice-cold EB,
containing an excess of unlabeled AA. Cells were then dissolved in 0.5M
NaOH and the incorporated radioactivity was measured by liquid scin-
tillation spectrometry. The 14C-AA non-speciﬁc binding to cells was
assayed by performing the experiments at 0 °C. No differences between
the controls (untreated samples) and 0 °C-14C-AA-treated sampleswere
detected.
2.5. Mitochondria isolation and subcellular fractionation
Mitochondria (M)were isolated either by differential centrifugation,
as detailed in [27] or by sucrose density gradient centrifugation, as de-
scribed by Koziel et al., [28]withminormodiﬁcations. The lattermethod
was also used to obtain the other sub-cellular fractions: nucleus (N),
plasma membranes (PM), endoplasmic reticulum (ER) and cytosol
(C). Brieﬂy, cells were washed twice in PBS and resuspended in cold ho-
mogenization buffer (HB: 225 mM mannitol, 75 mM sucrose, 0.1 mM
EGTA, 5mM Tris–HCl, pH 7.4), in presence of protease inhibitor cocktail
and digitonin (10 μg/ml) and homogenized using a glass potter in an
ice-bath. The efﬁciency of homogenization was monitored under the
microscope using trypan blue and stopped when the 90% of the total
cells was disintegrated. The homogenate was centrifuged at 1000×g
for 10 min at 4 °C and the supernatant (S1) was collected for the ﬁnal
centrifugation. The pellet was re-homogenized and the supernatant
(S2) added to S1 and centrifuged at 20000×g for 20min at 4 °C. The pellet
obtained, containing nucleus fraction (N), was maintained at−20 °C till
use. The supernatant was centrifuged at 100000×g for 60 min at 4 °C to
obtain the endoplasmic reticulum fraction (ER, pellet) and the cytosol
(C, supernatant). The pellet obtained from the centrifugation of S1 + S2
was resuspended in 5 mMMES, 0.2 mM EDTA pH 6.0 and separated by
centrifugation at 20000×g for 2 h at 4 °C on a discontinuous 38%, 43%
and 53% sucrose gradients. The middle density band corresponding to
mitochondrial fraction (M) and the high density band corresponding to
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HB at 20000×g for 20 min.2.6. Incubation of U937 cell mitochondria with 14C-AA
Isolatedmitochondriawere exposed for 3min to 14C-AA inmitochon-
drial buffer, MB (5 mMHEPES, 210 mMmannitol, 70 mM sucrose, 1 mM
Na–EGTA, pH 7.4) or intracellular buffer, IB (15 mM HEPES-Na, 15 mM
NaCl, 120 mM KCl, 1 mM MgCl2, pH 7.6) and processed as described
below. For experiments in Na+-free MB, Na–EGTA was replaced with
choline-chloride in EGTA Na+-free, while for experiments in Na+-free
IB, HEPES-Na+ and NaCl were replaced with choline-chloride in HEPES
Na+-free.
MB without EGTA was used in experiments aimed at evaluating the
role of cations in AA transport.
Uptake was stopped by rinsing the mitochondria with ice-cold MB
or IB, containing an excess of unlabeled AA. Mitochondrial pellets
were then dissolved in 0.5 M NaOH and the incorporated radioactivity
was measured by liquid scintillation spectrometry. The 14C-AA non-
speciﬁc binding to mitochondria was assayed by performing the exper-
iments at 0 °C. Nodifferences between the controls (untreated samples)
and 0 °C-14C-AA-treated samples were detected.2.7. Immunolocalization by confocal microscopy
U937 cells were incubated for 20 min with 50 nM MitoTraker Red
CMXRos (Molecular Probes, Europe, Leiden, The Netherlands) in 2 ml of
saline A (8.182 g/L NaCl, 0.372 g/L KCl, 0.336 g/L NaHCO3, and 0.9 g/L glu-
cose, pH7.4) and in 35mmglass bottomculture dishes (MatTek, Ashland,
MA). The cells were then ﬁxed for 1 min with 95% ethanol/5% acetic acid,
washedwith PBS (8 g/l NaCl, 1.15 g/l Na2HPO4, 0.2 g/l KH2PO4, and 0.2 g/l
KCl, pH 7.4) and blocked in PBS containing 2%w/v bovine serum albumin
(BSA) for 30min at room temperature. The cells were subsequently incu-
bated with goat polyclonal anti-SVCT2 antibody (1:100 in PBS containing
2% BSA), stored for 18 h at 4 °C, washed and then exposed to FITC-
conjugated secondary antibody diluted 1/100 in PBS for 2 h in the dark.
The digital images were acquired on a Leica TCS-SP5 CSLM mounted on
a Leica DMI 6000 CS inverted microscope (Leica Microsystems CMS
GmbH, Mannheim, Germany) at 1024 × 1024 using 63.0 × 1.4 oil objec-
tive (HCX PL APO 63.0 × 1.40 OIL UV) and with appropriate excitation⁄
detection settings (FITC argon laser 488 nm/500–535 nm emission ﬁlter;
MitoTracker RedHeNe laser 543nm/555–610nmemissionﬁlter). Images
and degree of co-localizationwere analysed by the Leica Application Suite
Advanced Fluorescence (LASAF) and ImageJ Software (Wayne Rasband,
Bethesda,MA). Semi-quantitative analysiswith the JACoPImageJ tool pro-
vided Pearson's (PC) and Manders' (M1 and 2) overlap coefﬁcients
(http://rsb.info.nih.gov/ij/plugins/track/jacop.html). The co-localization
of SVCT2 (green) with mitochondria (red) is shown as yellow (merged).
M1 indicates the overlap coefﬁcient of SVCT2 to mitochondria, while M2
signiﬁes the correlation of mitochondria overlapping SVCT2. The
Pearson's and Manders' overlap coefﬁcients are represented as the aver-
age of ten individual cells.2.8. Western blot assay
Equal amount (30 μg) of sub-cellular fractions andwhole cell lysates
were resolved in 12.5 or 15% sodium dodecyl sulphate polyacrylamide
gel and electrotransferred to polyvinyldiene diﬂuoride membranes.
Western blot analyses were performed using antibodies against
SVCT2, cytochrome c, calnexin, HSP-60, GLUT3 and lamin A. Details on
Western blotting apparatus and conditions are reported elsewhere
[29]. Antibodies against cytochrome c, calnexin, GLUT3 and lamin A
were used to assess the purity of the fractions; the antibody against
HSP-60 was used to assess the equal loading of the lanes.2.9. Kinetic calculations
The transport kinetic parameters were calculated by using the
Michaelis–Menten equation and the linear transformation of Eadie–
Hofstee. Kinetic parameters were estimated from the ﬁtted curves using
the Graph Pad Prism software designed for nonlinear regression analysis.
3. Results
3.1. Mitochondrial localization of anti-SVCT2 immunoreactivity
We performed immunocytochemical analysis of U937 cells labelled
with anti-SVCT2 antibodies andwith amitochondrial probe, MitoTracker
red CMXRos. Fig. 1 (A–D) provides the image of a single cell, however
representative of the remaining cells, inwhich the green identiﬁes the ex-
pression of SVCT2 (A), the red the mitochondria (B) and the yellow the
colocalized pixels in the overlay image (C). Co-localization analysis and
quantiﬁcation were also performed using Image J software, where back-
ground and threshold were set, generating a co-localization image (co-
localised pixels in white) (D). Panel E shows the Pearson's and Manders'
overlap coefﬁcients derived with the JACoPImageJ tool. The calculated
Pearson's coefﬁcient (PC)was 0.77 andManders' coefﬁcientM1 indicates
that 93.2% of the SVCT2 detected overlaps with CMXRos-stained mito-
chondria, thereby further emphasising the existence of a very high level
of co-localization of the two ﬂuorophores. Immunoblotting experiments
using mitochondria isolated by differential centrifugation as well as by
sucrose gradient centrifugation provided results coherent with the
aboveﬁndings (Fig. 1F).We next used an additionalmethod for subcellu-
lar fractionation to obtain nuclear, mitochondrial, plasma membrane,
endoplasmic reticulum and cytosol enriched fractions. As indicated in
Fig. 1G, SVCT2 expressionwas restricted to themitochondrial and plasma
membranes, in which expression of their respective markers, i.e., cyto-
chrome c for themitochondria [23] andGLUT3 for the plasmamembrane
(note that therewas noGLUT 3 expression in themitochondrial fraction),
as reported by other authors, [30,31] was also detected. A weak SVCT2
expression, probably associated with mitochondrial and plasma mem-
brane contaminations, was found in the nuclear fraction (expressing
lamin A) [32]. Lamin A expression was however absent in mitochondria
and plasmamembranes. An additional consideration is on the expression
of calnexin, a marker of the endoplasmic reticulum [24], also detected in
the plasma membrane fraction and, as a very weak band, in the mito-
chondrial fraction. It is however unlikely that such a contamination
(endoplasmic reticulum)provides the anti-SVCT2 reactivity to the plasma
membrane or mitochondrial fraction since no anti-SVCT2 reactivity was
found in the endoplasmic reticulum enriched fraction. There was no
SVCT2 immunoreactivity in the cytosol.
Collectively, these results are in keeping with the notion that
anti-SVCT2 antibodies recognise a protein(s) in mitochondria, as we
previously reported [23].
3.2. Kinetic properties of the mitochondrial transporter of AA
We examined the kinetic properties of the AA transporter in
mitochondria isolated fromU937 cells. Time course analysis of AAuptake,
performed inMB at a 30 μM substrate concentration, revealed that mito-
chondria take upAA at a constant rate of 0.48±0.055 nmol/mg prot/min
for at least 5 min (Fig. 2A). We next performed experiments using mito-
chondria exposed for 3 min to increasing concentrations of AA and
obtained a response described by a hyperbolic curve saturating at
60 μM AA (Fig. 2B). Analysis of the transport data by the Eadie–Hofstee
method (Fig. 2C) produced a straight line (r2 = 0.95), consistent
with the presence of a single functional component, allowing the cal-
culation of an apparent Km of 26.96 ± 1.46 μM and a Vmax of 1.24 ±
0.045 nmol/mg prot/min (n= 5). Experiments were next performed
using IB and AA concentrations up to 1.5 mM, as previous studies from
Muñoz-Montesino [24] identiﬁed a sigmoidal concentration response
Fig. 1. Sub-cellular localization of SVCT2 in U937 cells. (A–E) Co-localization of anti-SVCT2 immunoreactivity with a mitochondrial ﬂuorescent probe (MitoTracker Red CMXRos) in U937
cells. Representative ﬂuorescence images of cells double stained for SVCT2 (green, A) and mitochondria (red, B). In the merged images, the regions containing both MitoTracker Red
CMXRos and FITC ﬂuorescence appear yellow (C). (D) Co-localisation analysis and quantiﬁcation performed using Image J softwarewhere background and thresholdwere set, generating
a co-localization image (co-localised pixels in white). (E) The Pearson's (PC) and Manders' (M1 and M2) overlap coefﬁcients represented as the average of ten individual cells.
(F) Mitochondrial fractions obtained from two different lots of untreated U937 cells were processed for Western blot analysis using antibodies against SVCT2. Blots were re-probed for
HSP-60. Similar outcomeswere obtained in experiments using two additional cell preparations (not shown). Mitochondria were isolated by a differential centrifugation procedure (Method
1) or by sucrose gradient centrifugation (Method 2). (G) U937 cells were homogenized and fractionated by differential centrifugation and the different fractions (N: nuclear
fraction; M: mitochondria; ER: endoplasmic reticulum; PM: plasma membranes enriched fraction; C: cytoplasmic fraction) were processed for Western blot analysis using the following
antibodies: anti-SVCT2, anti-calnexin for ER, anti-lamin A for N, anti-cytochrome c for M, anti-GLUT3 for PM. Blots shown are representative of 2 separate experiments with similar
outcome.
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these experiments, a condition allowing the assessment of kinetic pa-
rameters under initial velocity conditions also after exposure to these
high AA concentrations (not shown). Results illustrated in Fig. 2D, how-
ever, are in keeping with those obtained with MB and analysis by the
Eadie–Hofstee method (Fig. 2E) revealed an apparent Km value of
22.4 ± 1.6 μM and a Vmax of 0.91 ± 0.036 nmol/mg prot/min. The
last set of experiments analysed the pH sensitivity of the mitochondrial
AA transporter. Results illustrated in Fig. 2F provide evidence for a pro-
gressive loss of activity at descending pH values.
We also performed experiments using intact Raw 264.7 cells, which
exclusively express SVCT2 (Fig. 3A, inset a). These cells were ﬁrst
exposed for 5 min to increasing concentrations of AA and then proc-
essed for the assessment of AA content. The concentration-dependent
accumulation of the vitamin is reported in the inset (b) to Fig. 3A.
Eadie–Hofstee analysis of these data (Fig. 3A) produced a straight line
(r2 = 0.95), as previously shown for U937 cell mitochondria (Fig. 2C
and E), allowing the calculation of a similar Km value (22.4 ± 1.7 μM).
To draw a comparison, similar experiments were performed in
U937 cells, which express both SVCT1 and 2 (Fig. 3B, inset a). These
experiments generated a hyperbolic dose–response curve (Fig. 3B,
inset b) that, when analysed by the Eadie–Hofstee method (Fig. 3B), re-
vealed a non-linear relationship that ﬁts well with a model describing
the involvement of two saturable transport systems for AA, each with
different afﬁnities for the substrate. The higher afﬁnity component
had an apparent transport Km of 8.4 ± 0.76 μM and Vmax of 0.11 ±0.007 nmol/mg prot/min, whereas the lower afﬁnity component
had apparent Km and Vmax values of 85.5 ± 7.9 μM and 0.48 ±
0.03 nmol/mg prot/min, respectively. These Km values fall within
the expected range for SVTC2 and for SVCT1 [2,33–35].
We ﬁnally determined in intact Raw 264.7 cells the pH effect of
plasma membrane SVCT2-dependent AA transport. Under these condi-
tions the sensitivity to extracellular pH (Fig. 3C)was remarkably similar
to that previously described by other authors [36,37]. It is interesting to
note that the pH sensitivity of mitochondrial SVCT2-dependent trans-
port of AA illustrated in Fig. 2F is also identical to the one described
for plasma membrane (Fig. 3C), in keeping with the notion that the
activity of mitochondrial SVCT2 is impaired at acid pH, as previously
observed in intact cells [36,37].
Taken together, the above results indicate that AA transport Km
values of mitochondrial and plasma membrane SVCT2 are remarkably
similar.
3.3. Na+-dependence of mitochondrial SVCT2
Plasma membrane SVCT2-mediated transport of AA is activated by
high Na+ concentrations, i.e., those normally detected in the extracellular
milieu [21]. The Na+-dependence of AA transport was therefore investi-
gated in mitochondria isolated from U937 cells. The results illustrated in
Fig. 4A are fromexperiments inwhichMBwas supplementedwith 30 μM
AA and increasing concentrations of Na+. These results clearly establish
theNa+-dependent activation of themitochondrial SVCT2 at surprisingly
Fig. 2. Kinetic properties of mitochondrial SVCT2. (A) Time-dependence of AA accumulation in isolated mitochondria exposed to 30 μM 14C-AA in MB. (B) AA content in isolated mito-
chondria exposed to 0–60 μM 14C-AA in MB. (C) Eadie–Hofstee plot of the data in B. (D) AA content in isolated mitochondria exposed to 0–1.5 mM 14C-AA/AA in IB. (E) Eadie–Hofstee
plot of the data in D. (F) AA uptake in isolated mitochondria exposed to 30 μM AA at different pH values in IB.
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creased linearly with increasing Na+ concentrations, reaching a plateau
at 1 mM, with a Na50 (the Na+ concentration inducing a 50% of the AA
maximal uptake rate) of 0.525 mM. We then performed similar experi-
ments in which MB was replaced with IB. As indicated in Fig. 4B, AA
uptake was somewhat increased under these conditions but, most
importantly, the plateau was reached once again at 1 mM Na+. The
sigmoidal curves outlined in Fig. 4A and B are indicative of a cooperative
mechanism, also emphasised by the Hill plot (insets to Fig. 4A
and B) leading to a calculated nH values of 2.2 ± 0.1 and 2.0 ± 0.16,
respectively.
We ﬁnally tested the Na+-dependence for AA transport in Raw
264.7 cells and obtained data in line with those previously reported in
other studies [21]. In particular, AA transport rate reached a plateau at
Na+ concentrations above 100 mM (Fig. 4C), with a remarkably lower
transport rate of the vitamin observed at 15 mM Na+, i.e. the cytosolic
concentration of the cation. Under these conditions, the Hill plot
(Fig. 4C, inset) led to a calculated nH values of 2.05 ± 0.19.
Taken together, these results show that AA transport is Na+-
dependent in the case of both the plasmamembrane andmitochondrial
SVCT2. In addition, an identical Na+ cooperativity was detected despite
the remarkably different levels of the cation necessary to maximally
activate AA transport in mitochondria or plasma membrane.
3.4. Ca++- and Mg++-dependence of mitochondrial SVCT2
Plasmamembrane SVCT2-mediated transport of AA has an absolute
requirement for Ca++ and Mg++ [21]. Coherently, omission of thesecations from the extracellular milieu abolished AA (30 μM) transport in
Raw 264.7 cells, whereas hardly any effect was obtained with omission
of either Ca++ or Mg++ alone (Fig. 5A). Results obtained in U937 cells
were somewhat different, as some residual AA transport activity was
found in the absence of both cations (Fig. 5A), most likely dependent
on SVCT1 activity.
These results are therefore different from those reported in Fig. 2B
(using isolated mitochondria), in which AA transport studies were
performed using a Ca++/Mg++-free buffer supplemented with EGTA
(MB). Further studies revealed that AA (30 μM) transport in isolated
mitochondria is not affected by removal of EGTA and is abolished by
Na+ omission, regardless of the presence of EGTA. Moreover, AA trans-
port rate in EGTA-freeMBwas insensitive to addition of Ca++ (0.25 μM)
and/or Mg++ (2.5 mM) (Fig. 5B). The Ca++ and/or Mg++ indepen-
dence of AA transport in isolated mitochondria was also established in
experiments in which MB was replaced with IB (not shown).
These results therefore indicate that mitochondrial SVCT2-dependent
AA transport is Ca++ andMg++-independent and is not further stimulat-
ed by increases in Ca++ and/or Mg++ concentrations.
4. Discussion
There is a growing interest on the effects of vitamin C in various sub-
cellular compartments and a need to understand the speciﬁc relevance of
the transport mechanisms involved in its accumulation in these speciﬁc
sites. Mitochondria represent an important example, as vitamin C is ex-
pected to play an array of critical functions in these organelles in which,
for the reasons summarised in the Introduction section, DHA uptake
Fig. 3. Ascorbic acid transport in Raw 264.7 and U937 cells. (A) Eadie –Hofstee plot of the
concentration-response curve for AA transport in Raw264.7 cells. Inset (a): Raw264.7 cell
lysates were processed for Western blot analysis using antibodies against SVCT1 and
SVCT2. Inset (b): AA content in Raw 264.7 cells exposed to 0–100 μM 14C-AA in EB.
(B) Eadie–Hofstee plot of the concentration–response curve for AA transport in U937
cells. Inset (a): U937 cell lysateswere processed forWestern blot analysis using antibodies
against SVCT1 and SVCT2. Inset (b): AA content in U937 cells exposed to 0–100 μMAA in EB.
(C)AAuptake in Raw264.7 cells exposed to 30 μMAAatdifferent pHvalues in EB. Values are
means, with standard deviations calculated from at least three separate experiments.
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Based on these considerations, we were initially surprised to detect
anti-SVCT2 immunoreactivity in the mitochondria isolated from U937
cells [23]. The present work implements these observations with the
direct detection of a punctuate ﬂuorescence response elicited by the
anti-SVCT2 antibodies, largely colocalizing with the ﬂuorescence elicited
by a mitochondrial probe (Fig. 1A–E), and with the identiﬁcation of the
same bands in immunoblot experiments using anti-SVCT2 antibodies
and mitochondrial preparations, obtained with two different isolation
procedures (Fig. 1F). The mitochondrial localization of SVCT2 is also con-
sistent with the results obtained in immunoblotting experiments using
markers for the nuclear, mitochondrial, plasma membrane, endoplasmic
reticulum and cytosol enriched fractions (Fig. 1G). These results are
therefore in line with the ﬁndings of the elegant and comprehensive
work of Muñoz-Montesino et al. [24], that provided solid scientiﬁc
ground to support our initial observation on the mitochondrial SVCT2
[23].
Themost important ﬁnding obtained in this study is however on the
afﬁnity of the mitochondrial AA transporter, which would be expected
to be low if the requirements for optimal activity were the same as
those of the plasma membrane transporter [21]. This prediction, how-
ever, was not conﬁrmed by the results of our kinetic studies, providing
evidence for a mitochondrial transport of AA, saturating at 5 min
(Fig. 2A), characterised by a dose–response curve (Fig. 2B) which,
analysed by the Eadie–Hofstee method (Fig. 2C), leads to a Km of
26.96 ± 1.46 μM. It is interesting to note that similar experiments using
a K+-containing buffer produced identical results (Fig. 2D and E) with
an even lower Km (22.40 ± 1.6 μM), despite the recent indication that
K+ may in fact reduce the afﬁnity of the mitochondrial AA transporter
[24]. Km values calculated in our studies are remarkably similar to those
reported by other authors for plasma membrane transport in various
cell types [2,21,38,39]. We also report a Km of 22.4 ± 1.66 μM for AA up-
take in Raw 264.7 cells (Fig. 3A), which only express SVCT2 (Fig. 3A, inset
a). In U937 cells, which express both SVCT1 and 2 (Fig. 3B, inset a), the
SVCT2 Km value obtained, 8.4 ± 0.76 μM (Fig. 3B), is similar to SVCT2
Km values in cellular systems expressing both transporters [2,33–35].
An additional important similarity was found for the pH-dependent reg-
ulation of SVCT2-mediated AA transport. Our results obtained with intact
Raw 264.7 cells (Fig. 3C) are in keepingwith the notion that SVCT2 activ-
ity is impaired at acid pH [36,37] and a virtually superimposable curve
was obtained in experiments performed with isolated mitochondria
(Fig. 2F).
In summary, our results provide evidence for remarkable similarities
between the mitochondrial AA transporter and the plasma membrane
SVCT2, including the very low Km values. As in the case of the plasma
membrane SVCT2, the mitochondrial AA transporter was also found to
interact with Na+ in a cooperative manner, but required 100 times
less Na+ for maximal activity (Fig. 4A and B). This observation is com-
patible with, and provides an explanation for, the unexpected high
afﬁnity of a transporter expressing maximal activity in an intracellular
environment, characterised by concentrations of Na+ largely lower that
those necessary to maximally drive AA transport through the plasma
membrane (Fig. 4C). It should be also noted that the use of a low
(Fig. 4A) vs high (Fig. 4B) K+ medium produces hardly any effect on
the Na+-dependent regulation of mitochondrial AA transport. Additional
important information, also coherentwith the expression of themaximal
activity in an intracellular environment, is that i) the mitochondrial AA
transporter was fully active also in the absence of Ca++ and Mg++ and
that ii) transport activity was not affected by the addition of each, or
both, of these cations (Fig. 5).
The above results are of complex interpretation. For example, it
appears very difﬁcult to ﬁnd a reasonable explanation for the need of
only 1 mM Na+ to maximally support mitochondrial transport of AA,
whereas a 10-fold difference in the extra vs intracellular Na+ concentra-
tions is instead necessary to achieve the same result for the plasma
membrane SVCT2. It is important to note that our experiments were
Fig. 4. Na+-dependence of ascorbic acid transport in mitochondria isolated from U937 cells and in intact Raw 264.7 cells. (A) Effect of increasing Na+ concentrations on 14C-AA (30 μM)
uptake in isolated U937 cell mitochondria bathed in MB. Inset: Hill plot of the data in A. (B) Effect of increasing Na+ concentrations on 14C-AA (30 μM) uptake in isolated U937 cell
mitochondria bathed in IB. Inset: Hill plot of the data in B. (C) Effect of increasing Na+ concentrations on AA (30 μM) uptake in intact Raw 264.7 cells bathed in EB. Inset: Hill plot of
the data in C. Values are means, with standard deviations calculated from at least three separate experiments.
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intramitochondrial concentration of Na+ after the isolation procedure
of these organelles. We can however predict that, as normally observed
in intact cells [40], the ratio is maintained close to 1, which then raises
concerns for the formation of the electrochemical gradient necessary
for AA transport. Clearly, more studies are necessary to provide an
answer to such an intriguing question and to ﬁnd an explanation
for the K+-independence of the low Km transporter (Fig. 2B and
D) vs the reported inhibitory response mediated by K+ on the low
Km transporter [24]. The possible answer for the different cation de-
pendence is likely based on the different compositions of the inner
mitochondrial membrane vs plasma membrane, which may favour in-
teractions with speciﬁc components and result in different structural
organization.
An additional important question to be asked is why cells should use
a lowKmactive transport for mitochondrial AA uptake in vivo. Most cell
types indeed contain large amounts of the vitamin in their cytosol [2,3,
10]. The question, rephrased, would then be why should cells use a
mitochondrial transporter always working at saturating substrate con-
centrations? Does it make sense? The obvious answer is clearly that
high afﬁnity transport is relevant when the substrate concentration is
low but nevertheless this phenomenon is not unique. For example, we
should keep in mind that SVCT2 is largely expressed in the plasma
membrane of neurons bathed in a milieu containing 200/400 μM AA
[41]. The substrate saturation phenomenon is therefore observed in
different contexts and hence appears of plausible physiological sig-
niﬁcance. We therefore believe that the apparent dichotomy existing
between the low Km of the transporter and the high substrate concen-
tration could be justiﬁed by the existence of mechanisms regulating
transporter activity (in speciﬁc cell types or in the mitochondria of spe-
ciﬁc cells types) by direct inhibition, as we recently describedwith DHA
[42]. Exogenous molecules, as quercetin of phloretin [43], or the activa-
tion of speciﬁc signal transduction pathways [44], may also regulate AA
transporter activity.
Our results are therefore unexpected, but nevertheless appear of
likely physiological signiﬁcance, at least for some cell types. For other
cell types there is the more straightforward possibility, proposed by
Godoy et al. [21], that SVCT2 exists in two different functional states de-
ﬁned by their respective subcellular localization. Which, reinterpreted,
means that themitochondrial AA transporter should display a low afﬁnitysince the conditions are not permissive for the expression of optimal ac-
tivity. In a recent study [24], the same group reported that this transport
activity is indeed characterised by a low afﬁnity. In this perspective mito-
chondrial transport of the vitamin appears regulated by the low afﬁnity of
the transporter.
We have two additional considerations on our ﬁndings. The ﬁrst one
is that the discovery of functional SVCT2 expression in mitochondria
will most likely foster the research on the biological and physiopatho-
logical relevance [45] of AA subcellular compartmentalization and on
the mechanisms regulating these events. In this context, the same
heterogenicity observed for plasma membrane SVCT2 in different cell
types and conditions is to be expected also for the mitochondrial form
of the transporter. At least in principle, different cell types could meet
their requirements for mitochondrial AA accumulation with the use of
high or low afﬁnity transporters, or none of them, thereby limiting the
access to the oxidized form of the vitamin. Clearly, much more work is
needed to determinewhether the above possibilities are indeed correct
or are in fact confuted by the experimental evidence.
The second consideration is still based on the concept of hetero-
genicity. The existence of low afﬁnity transport in cultured cells detected
in the work by Muñoz-Montesino et al. [24] rules out the possibility that
the high afﬁnity transport detected in our cells arises as a consequence
of a cell culture effect associated with the growth of the cells in AA-free
medium. Coherently, experiments in progress in our laboratory demon-
strate the presence of a low afﬁnity transport of AA in the mitochondria
derived from Raw 264.7 cells (not shown) grown in the same medium
in which the U937 cells are also grown.
The mitochondrial localization of vitamin C has thus far received
very little attention, although there are reasons to predict important
effects in an array of mitochondrial events. In this perspective, the
mechanisms whereby vitamin C is taken up by these organelles appear
of pivotal importance. For example, we recently found that sequential
activities of high afﬁnity transporters of AA in the plasma membrane
and mitochondria effectively prevent apoptosis mediated by arsenite,
a toxic compounds directly targeting mitochondria [46]. In addition,
cytoprotection is observed after exposure to extremely low concentra-
tions of the vitamin and appears exclusively associated with its mito-
chondrial fraction.
In conclusion, our work provides further evidence for themitochon-
drial localization of SVCT2 in U937 cells and demonstrates that this
Fig. 5. Ca++ and/or Mg++-dependence of ascorbic acid transport in intact Raw 264.7 cells, U937 cells and mitochondria isolated from U937 cells. (A) Raw 264.7 and U937 cells were
exposed to 14C-AA (30 μM) in EB manipulated as indicated in the ﬁgure. AA uptake was then determined. (B) Mitochondria isolated from U937 cells were exposed to 14C-AA (30 μM)
in MB manipulated as indicated in the ﬁgure and then analysed for AA accumulation. Values are means, with standard deviations calculated from at least three separate experiments.
1400 M. Fiorani et al. / Biochimica et Biophysica Acta 1848 (2015) 1393–1401transporter, because of the very low requirements for Na+ and divalent
cations, has an afﬁnity comparable with that of the plasma membrane
SVCT2. While future studies should address the generality and molecu-
lar bases of this phenomenon, these results nevertheless imply that
different cell types might accumulate vitamin C in their mitochondria
through both high and low afﬁnity SVCT2.Funding sources
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